이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
DaVita 미래 성장
Future 기준 확인 1/6
DaVita (는) 각각 연간 2.3% 및 3.6% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 9.9% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 139.5% 로 예상됩니다.
주요 정보
2.3%
수익 성장률
9.9%
EPS 성장률
Healthcare 수익 성장 | 19.3% |
매출 성장률 | 3.6% |
향후 자기자본 수익률 | 139.5% |
애널리스트 커버리지 | Good |
마지막 업데이트 | 12 Sep 2024 |
최근 미래 성장 업데이트
Recent updates
An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued
Sep 16DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business
Sep 01DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet
Jul 02Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?
Jun 19Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?
Jun 04Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes
May 22DaVita Stock Is A Hold As It Expands In Latin America
Mar 18Market Might Still Lack Some Conviction On DaVita Inc. (NYSE:DVA) Even After 27% Share Price Boost
Mar 13Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?
Mar 04DaVita Inc. (NYSE:DVA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 16Is DaVita (NYSE:DVA) Using Too Much Debt?
Feb 08DaVita: Assessing After The Rally
Dec 29DaVita Inc.'s (NYSE:DVA) Subdued P/E Might Signal An Opportunity
Dec 24DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet
Nov 08DaVita: Simple And Compelling After Sell-Off
Oct 26Returns On Capital Signal Difficult Times Ahead For DaVita (NYSE:DVA)
Oct 25DaVita: Continued Economic Hurdles, Market Expectations May Be Correct
Oct 05Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?
Aug 14DaVita (NYSE:DVA) Takes On Some Risk With Its Use Of Debt
Jul 31DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold
Jul 21Returns At DaVita (NYSE:DVA) Appear To Be Weighed Down
Jul 18DaVita Inc. (NYSE:DVA) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jul 03What Is DaVita Inc.'s (NYSE:DVA) Share Price Doing?
May 01These 4 Measures Indicate That DaVita (NYSE:DVA) Is Using Debt Extensively
Apr 17Investors Met With Slowing Returns on Capital At DaVita (NYSE:DVA)
Apr 03Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 40%?
Mar 08DaVita HealthCare Partners Q4 2022 Earnings Preview
Feb 21Moon Capital - DaVita: A Recession-Resistant Cash Generating Machine
Feb 08Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?
Jan 24Is DaVita (NYSE:DVA) A Risky Investment?
Jan 09DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution
Dec 12DaVita Q3 2022 Earnings Preview
Oct 27Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?
Oct 18DaVita: Solid Valuation And Cash Flow, Price Recovering After SCOTUS Ruling
Sep 28DaVita could benefit from legislation that would return dialysis protection to Medicare
Aug 16We Think DaVita (NYSE:DVA) Is Taking Some Risk With Its Debt
Aug 14수익 및 매출 성장 예측
날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
---|---|---|---|---|---|
12/31/2026 | 13,703 | 870 | N/A | 2,427 | 4 |
12/31/2025 | 13,263 | 867 | N/A | 2,214 | 7 |
12/31/2024 | 12,744 | 847 | 855 | 2,160 | 7 |
6/30/2024 | 12,524 | 860 | 1,269 | 1,810 | N/A |
3/31/2024 | 12,338 | 816 | 920 | 1,462 | N/A |
12/31/2023 | 12,140 | 692 | 1,491 | 2,059 | N/A |
9/30/2023 | 11,911 | 596 | 1,314 | 1,918 | N/A |
6/30/2023 | 11,739 | 454 | 1,357 | 1,967 | N/A |
3/31/2023 | 11,665 | 500 | 1,077 | 1,705 | N/A |
12/31/2022 | 11,610 | 547 | 961 | 1,565 | N/A |
9/30/2022 | 11,637 | 680 | 1,152 | 1,751 | N/A |
6/30/2022 | 11,627 | 834 | 995 | 1,607 | N/A |
3/31/2022 | 11,616 | 903 | 1,479 | 2,099 | N/A |
12/31/2021 | 11,619 | 978 | 1,289 | 1,931 | N/A |
9/30/2021 | 11,580 | 984 | 1,209 | 1,886 | N/A |
6/30/2021 | 11,566 | 883 | 1,124 | 1,802 | N/A |
3/31/2021 | 11,529 | 791 | 1,108 | 1,773 | N/A |
12/31/2020 | 11,551 | 783 | 1,304 | 1,979 | N/A |
9/30/2020 | 11,544 | 832 | 1,506 | 2,175 | N/A |
6/30/2020 | 11,524 | 824 | 1,648 | 2,333 | N/A |
3/31/2020 | 11,487 | 816 | 2,112 | 2,834 | N/A |
12/31/2019 | 11,388 | 705 | 1,730 | 2,496 | N/A |
9/30/2019 | 11,311 | 623 | 1,406 | 2,235 | N/A |
6/30/2019 | 11,253 | 548 | 1,124 | 2,011 | N/A |
3/31/2019 | 11,300 | 551 | 255 | 1,208 | N/A |
12/31/2018 | 11,412 | 616 | 544 | 1,531 | N/A |
9/30/2018 | 11,378 | 617 | 621 | 1,592 | N/A |
6/30/2018 | 11,299 | 698 | 698 | 1,679 | N/A |
3/31/2018 | 11,110 | 652 | N/A | 1,470 | N/A |
12/31/2017 | 10,884 | 909 | N/A | 1,966 | N/A |
9/30/2017 | 7,773 | 1,065 | N/A | 1,983 | N/A |
6/30/2017 | 8,732 | 1,480 | N/A | 2,016 | N/A |
3/31/2017 | 9,747 | 1,382 | N/A | 2,391 | N/A |
12/31/2016 | 10,696 | 1,038 | N/A | 1,988 | N/A |
9/30/2016 | 14,550 | 716 | N/A | 1,918 | N/A |
6/30/2016 | 14,347 | 361 | N/A | 2,061 | N/A |
3/31/2016 | 14,065 | 478 | N/A | 1,576 | N/A |
12/31/2015 | 9,973 | 323 | N/A | 1,531 | N/A |
9/30/2015 | 13,565 | 484 | N/A | 1,051 | N/A |
6/30/2015 | 13,290 | 452 | N/A | 1,219 | N/A |
3/31/2015 | 13,027 | 429 | N/A | 1,450 | N/A |
12/31/2014 | 12,781 | 723 | N/A | 1,459 | N/A |
9/30/2014 | 12,519 | 727 | N/A | 1,884 | N/A |
6/30/2014 | 12,270 | 680 | N/A | 1,769 | N/A |
3/31/2014 | 11,971 | 787 | N/A | 1,813 | N/A |
12/31/2013 | 11,759 | 620 | N/A | 1,773 | N/A |
9/30/2013 | 11,174 | 564 | N/A | 1,619 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: DVA 의 연간 예상 수익 증가율( 2.3% )이 saving rate( 2.5% 미만입니다. ).
수익 vs 시장: DVA 의 연간 수익( 2.3% ) US 시장( 15.2% 보다 느리게 성장할 것으로 예상됩니다. 15.2% 연간).
고성장 수익: DVA 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: DVA 의 수익(연간 4.1% ) US 시장( 8.7% 보다 느리게 성장할 것으로 예상됩니다. 8.7% 연간).
고성장 수익: DVA 의 수익(연간 4.1% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: DVA 의 자본 수익률은 3년 내에 매우 높을 것으로 예상됩니다( 59.5 %).